Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 8/20 | 0.53 |
| ▸ | PPARG | P37231 | 4/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | PPARA | Q07869 | 2/20 | 0.49 |
| ▸ | FABP2 | P12104 | 1/20 | 0.49 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.49 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.49 |
| ▸ | STS | P08842 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24360977 | 0.88 | LMNA (0.52) | ELANEPPARGALDH1A1PPARAFABP2 | |
| SCHEMBL4602009 | 0.85 | ELANE (0.56) | ELANEPPARGALDH1A1SRD5A2STS | |
| SCHEMBL17674534 | 0.85 | SSTR4 (0.43) | PPARGALDH1A1PPARAGAA | |
| SCHEMBL23518959 | 0.81 | PARP10 (0.54) | ALDH1A1 | |
| SCHEMBL2555649 | 0.80 | MAPT (0.53) | PPARGALDH1A1PPARAFABP2SLC22A12 | |
| SCHEMBL23519346 | 0.80 | HPGD (0.62) | ELANEALDH1A1SRD5A2STSGAA | |
| SCHEMBL27782640 | 0.79 | ELANE (0.58) | ELANEPPARGALDH1A1PPARAFABP2 | |
| SCHEMBL23519349 | 0.79 | STS (0.55) | PPARGPPARASRD5A2STS | |
| SCHEMBL23519065 | 0.79 | EPHX2 (0.55) | GAA | |
| SCHEMBL11441192 | 0.79 | PPARG (0.76) | ELANEPPARGALDH1A1PPARAFABP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230132653-A1 | MOLECULAR RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20230132653-A1 | MOLECULAR RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| US-20220177424-A1 | RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING RESIST PATTERN | JSR CORPORATION (JP) | 2022-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220177424-A1 | RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING RESIST PATTERN | RER1, RARA, ARCN1 | ELANE 1200/4885PPARG 2909/4885ALDH1A1 2356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.